Editorial
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
6
Page:
1-2
Author(s):
Khurshid Zaman
Has Bevacizumab (Avastin) Given Extra Therapeutic Gain in Metastatic Colorectal Cancer and Malignant Brain Gliomas? Systematic Review Answering this Question
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
6
Page:
70-77
Author(s):
Georgios V. Koukourakis
Patent Selections
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
6
Page:
88-90
Author(s):
Circulating Tumor Stem Cells as Biomarkers for Cancer Progression
Journal:
Recent Patents on Biomarkers
Volume:
2
Page:
36-53
Author(s):
Olatz Leis, Paz Lopez-Mato and Angel G. Martin
Therapeutic Polycomb Targeting in Human Cancer
Journal:
Recent Patents on Regenerative Medicine
Volume:
2
Page:
22-29
Author(s):
Lorena Arranz, Antonio Herrera-Merchan and Susana Gonzalez
Transforming Growth Factor Beta in Pancreatic Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2158-2164
Author(s):
Andreas Hilbig and Helmut Oettle
Biology of Transforming Growth Factor-β Signaling
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2099-2107
Author(s):
Hiroaki Ikushima and Kohei Miyazono
The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2138-2149
Author(s):
Erin C. Connolly and Rosemary J. Akhurst
Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2121-2137
Author(s):
Jeroen T. Buijs, Patricia Juarez and Theresa A. Guise
Editorial [Hot Topic: TGF-β As Target in Oncology (Guest Editor: Karl-Hermann Schlingensiepen)]
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2080-2080
Author(s):
Karl-Hermann Schlingensiepen